Sharekhan's research report on Cipla
Cipla reported muted results for Q3FY2020. PAT missed estimates. India business is on strong footing with the management looking to merge all the three segments in the India business under one, leading to generation of significant synergies. Strong new launch line up is expected to drive the US business. We expect Cipla’s topline and PAT to clock a CAGR of 13% and 23%, respectively, over the next two years.
Outlook
We maintain our Buy recommendation on the stock with an unchanged PT of Rs. 540.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!